Cite

HARVARD Citation

    de Tena, P. et al. (2022). Allogeneic CD34‐selected stem cell boost as salvage treatment of life‐threatening infection and severe cytopenias after CAR‐T cell therapy. Transfusion. 62 (10), pp. 2143-2147. [Online]. 
  
Back to record